Paradigm Financial Advisors adds CVS Health Corp (CVS) to its portfolio

CVS Health Corp (CVS) : Paradigm Financial Advisors added new position in CVS Health Corp during the most recent quarter end. The investment management firm now holds 2,488 shares of CVS Health Corp which is valued at $252,383 , the company said in a statement filed on Apr 21, 2016 with the SEC.CVS Health Corp makes up approximately 0.15% of Paradigm Financial Advisors’s portfolio.

CVS Health Corp closed down -0.15 points or -0.15% at $102.7 with 31,50,430 shares getting traded on Wednesday. Post opening the session at $102.98, the shares hit an intraday low of $101.91 and an intraday high of $103.419 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

Other Hedge Funds, Including , Weatherly Asset Management L. P. boosted its stake in CVS in the latest quarter, The investment management firm added 1,309 additional shares and now holds a total of 23,190 shares of CVS Health Corp which is valued at $2,352,394. CVS Health Corp makes up approx 0.80% of Weatherly Asset Management L. P.’s portfolio.Redwood Investments boosted its stake in CVS in the latest quarter, The investment management firm added 2,740 additional shares and now holds a total of 293,216 shares of CVS Health Corp which is valued at $29,743,831. CVS Health Corp makes up approx 2.92% of Redwood Investments’s portfolio.Pinnacle Advisory Group boosted its stake in CVS in the latest quarter, The investment management firm added 242 additional shares and now holds a total of 7,853 shares of CVS Health Corp which is valued at $802,891. CVS Health Corp makes up approx 0.08% of Pinnacle Advisory Group’s portfolio.Lowe Fs boosted its stake in CVS in the latest quarter, The investment management firm added 1 additional shares and now holds a total of 160 shares of CVS Health Corp which is valued at $16,358. CVS Health Corp makes up approx 0.01% of Lowe Fs’s portfolio.

On the company’s financial health, CVS Health Corp reported $1.53 EPS for the quarter, based on the information available during the earnings call on Feb 9, 2016. Analyst had a consensus estimate of $1.53. The company had revenue of $41145.00 million for the quarter, compared to analysts expectations of $41126.27 million. The company’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.21 EPS.

Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Shares were Reiterated by Mizuho on Feb 10, 2016 to “Buy” and Lowered the Price Target to $ 104 from a previous price target of $113 .CVS Health Corp was Initiated by Atlantic Equities to “Overweight” on Feb 3, 2016.

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Leave a Reply

CVS Health Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on CVS Health Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.